Taboco, Naome .
HRN: 23-03-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2023
CEFUROXIME 500MG (TAB)
11/19/2023
11/26/2023
PO
500 Mg
BID
S/P TAHBSO
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes